N-methyl-N-[2-(4-methylanilino)-2-oxoethyl]-2-[(5S,6S)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide

C21H28N4O4 — CID 9493069

IUPACN-methyl-N-[2-(4-methylanilino)-2-oxoethyl]-2-[(5S,6S)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide
SMILESCc1ccc(NC(=O)CN(C)C(=O)CN2C(=O)N[C@]3(CCCC[C@@H]3C)C2=O)cc1
InChIInChI=1S/C21H28N4O4/c1-14-7-9-16(10-8-14)22-17(26)12-24(3)18(27)13-25-19(28)21(23-20(25)29)11-5-4-6-15(21)2/h7-10,15H,4-6,11-13H2,1-3H3,(H,22,26)(H,23,29)/t15-,21-/m0/s1
InChIKeyHAKFIOYLFDBBEU-BTYIYWSLSA-N
MW400.48 g/mol
LogP1.89
Rot. Bonds5

About N-methyl-N-[2-(4-methylanilino)-2-oxoethyl]-2-[(5S,6S)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide

N-methyl-N-[2-(4-methylanilino)-2-oxoethyl]-2-[(5S,6S)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide (PubChem CID 9493069) has the molecular formula C21H28N4O4 and a molecular weight of 400.48 g/mol. Its IUPAC name is N-methyl-N-[2-(4-methylanilino)-2-oxoethyl]-2-[(5S,6S)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide.

Molecular Properties

Compound NameN-methyl-N-[2-(4-methylanilino)-2-oxoethyl]-2-[(5S,6S)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide
PubChem CID9493069
Molecular FormulaC21H28N4O4
Molecular Weight400.48 g/mol
Exact Mass400.21
IUPAC NameN-methyl-N-[2-(4-methylanilino)-2-oxoethyl]-2-[(5S,6S)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide
SMILESCc1ccc(NC(=O)CN(C)C(=O)CN2C(=O)N[C@]3(CCCC[C@@H]3C)C2=O)cc1
InChIInChI=1S/C21H28N4O4/c1-14-7-9-16(10-8-14)22-17(26)12-24(3)18(27)13-25-19(28)21(23-20(25)29)11-5-4-6-15(21)2/h7-10,15H,4-6,11-13H2,1-3H3,(H,22,26)(H,23,29)/t15-,21-/m0/s1
InChIKeyHAKFIOYLFDBBEU-BTYIYWSLSA-N
XLogP1.89
TPSA98.82 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms29
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500400.48
LogP ≤ 51.89
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydantoin', 'substructure': 'N/A'}

Analyze N-methyl-N-[2-(4-methylanilino)-2-oxoethyl]-2-[(5S,6S)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-methyl-N-[2-(4-methylanilino)-2-oxoethyl]-2-[(5S,6S)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide?
The IUPAC name of N-methyl-N-[2-(4-methylanilino)-2-oxoethyl]-2-[(5S,6S)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide (CID 9493069) is N-methyl-N-[2-(4-methylanilino)-2-oxoethyl]-2-[(5S,6S)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide.
What is the SMILES notation for N-methyl-N-[2-(4-methylanilino)-2-oxoethyl]-2-[(5S,6S)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide?
The canonical SMILES for N-methyl-N-[2-(4-methylanilino)-2-oxoethyl]-2-[(5S,6S)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide is Cc1ccc(NC(=O)CN(C)C(=O)CN2C(=O)N[C@]3(CCCC[C@@H]3C)C2=O)cc1.
What is the InChIKey of N-methyl-N-[2-(4-methylanilino)-2-oxoethyl]-2-[(5S,6S)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide?
The InChIKey is HAKFIOYLFDBBEU-BTYIYWSLSA-N. The full InChI is InChI=1S/C21H28N4O4/c1-14-7-9-16(10-8-14)22-17(26)12-24(3)18(27)13-25-19(28)21(23-20(25)29)11-5-4-6-15(21)2/h7-10,15H,4-6,11-13H2,1-3H3,(H,22,26)(H,23,29)/t15-,21-/m0/s1.
What are the key properties of N-methyl-N-[2-(4-methylanilino)-2-oxoethyl]-2-[(5S,6S)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide?
N-methyl-N-[2-(4-methylanilino)-2-oxoethyl]-2-[(5S,6S)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide has a molecular weight of 400.48 g/mol, XLogP of 1.89, 5 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-methyl-N-[2-(4-methylanilino)-2-oxoethyl]-2-[(5S,6S)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide is sourced from PubChem (CID 9493069), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).